Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Templeton Emerging Markets Investment Trust Plc (TEM) / HY22

TEMIT swings to NZD 191.8m half-year loss on -7.5% portfolio return

Investment income fell 6.3% and emerging-markets capital losses drove the swing, though revenue earnings still cover ~98% of distributions.

Investment Companies / Listed investment trust

NTA/NAV per share

Net tangible asset or net asset value per share, shown in per-share cents for chart readability.

↗
Loading chart...
HY22 was 200.3c, versus 1,096.9c in FY21.

Investment income

Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.

↗
Loading chart...
HY22 was $32.3m, versus $59.9m in FY21.

Investment total return

Total income or return including fair-value or capital movement where disclosed.

↗
Loading chart...
HY22 was -$191.9m, versus $947.7m in FY21.

Net assets attributable

Net asset base attributable to shareholders or unitholders.

↗
Loading chart...
HY22 was $2.4b, versus $2.6b in FY21.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 8 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$6.9b

i

End-of-day close multiplied by current shares on issue.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

1.6%

i

Trailing dividends compared with the latest close.

Premium / discount

334.0%

i

For investment companies, price compared with reported NTA.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not available for this company right now.

EPS

Not available

i

Not available for this company right now.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not useful for this reporting shape.

P/FCF

Not available

i

Not available for this company right now.

Release date
25 November 2021
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

HY22 vs HY21

Net profit after tax

−$191.8m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

$23.4m

-50.9% ↓ vs $47.6m

Operating profit

$27.9m

-94.7% ↓ vs $524.2m

Profit before tax

−$185.2m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$40.7m

-58.3% ↓ vs $97.8m

Total assets

$2.4b

+0.9% ↑ vs $2.3b

What changed

The trust's bottom line reversed sharply as portfolio mark-to-market turned negative

NPAT swung to -NZD 191.8m from +NZD 543.6m a year earlier (-135.3%), and PBT to -NZD 185.2m from +NZD 522.9m (-135.4%). The driver was a portfolio total return of -7.5% over the half, not a deterioration in the recurring income engine.

Investment income (revenue earnings) fell 6.3% to NZD 32.3m, with dividends received holding broadly steady at NZD 32.2m and "other income" collapsing from NZD 2.9m to NZD 0.1m. Despite the half-year loss, net assets ended at NZD 2.4b, up 5.6% on the prior comparable balance date, reflecting earlier H2 FY21 gains. NTA per share stood at NZD 2.003. Cash on hand fell to NZD 40.7m from NZD 97.8m, while gross borrowings were essentially unchanged at NZD 100.5m.

What matters

Portfolio capital reversal dominates the result

Because this is an investment trust, reported profit moves with fair-value changes on holdings; the -7.5% portfolio return mechanically drives the swing into loss. It is a price movement on emerging-markets equities rather than evidence that the trust's income-generating capacity has been impaired. This matters because the recurring revenue line and the capital return line should be read separately when judging quality.

The income engine is broadly intact and distributions are nearly self-funded. Investment income of NZD 32.3m, against an expense ratio of 0.97%, supported distribution coverage of 97.8% on the supplied basis. The 6.3% income decline is meaningful but modest relative to the -135% NPAT print, which is the cleaner read on the underlying yield-generating function.

NAV growth has flattered the longer view. Net assets are up 5.6% versus end-HY21, but that is over 12 months and incorporates the strong H2 FY21 that lifted FY21 NPAT to NZD 934.4m. The current half on its own has consumed roughly NZD 192m of that earlier capital appreciation, so the year-on-year NAV comparison should not be read as a sign that the current half was a good outcome.

Expectations

No quantitative forward targets were provided

Chairman commentary notes that the majority of TEMIT's revenue earnings are typically received in H1, and the FY21 pattern bears that out: HY21 revenue of NZD 34.5m was higher than the NZD 28.6m full-year figure, implying a small negative print in H2 FY21. On that seasonality, H2 FY22 income should be expected to step down materially from the NZD 32.3m booked this half, which would pressure forward distribution coverage if payout pace is maintained.

The release does not support any view on the path of the portfolio return into H2; that depends on emerging-markets price action rather than anything specific to this filing.

Quality of result

The result is overwhelmingly mark-to-market in nature, so its "quality" question is different from an operating company

The income component, NZD 32.3m of dividends and other receipts, is the durable piece and held within ~6% of the prior comparable. Net cash inflow from operating activities of NZD 23.4m broadly tracks that revenue earnings line. The -NZD 191.8m bottom line is capital-account, not cash-account, and reverses in future periods if markets recover.

The drop in cash from NZD 97.8m to NZD 40.7m, against essentially flat borrowings, is consistent with deployment, distributions paid, and/or buyback activity rather than operating stress, but the release does not segregate these uses cleanly in the excerpts supplied. Distribution coverage at 97.8% indicates the payout is being met from revenue earnings rather than capital, which is the right side of the line for an income-oriented trust.

Unresolved

Open questions

What were the principal country, sector and stock-level detractors behind the -7.5% portfolio total return for the half?
How does management intend to defend distribution coverage if H2 revenue earnings follow the typical seasonal step-down from H1?
What drove the NZD 57m reduction in cash balances and how much of that was investment deployment versus distributions paid or buybacks?
Does the 6.3% decline in investment income reflect a normalisation from a prior-period tax repayment, as suggested in earlier commentary, or underlying dividend-yield compression in holdings?
How does management view gearing at NZD 100.5m of borrowings against a portfolio that has just delivered a negative return?

This briefing cannot assess country, sector or single-stock attribution of the portfolio return without holdings-level disclosures, nor verify the benchmark comparison figure supplied in the structured data.

Chat

Ask about TEM HY22

Ask follow-up questions about Templeton Emerging Markets Investment Trust Plc's HY22 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about TEM HY22

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Templeton Emerging Markets Investment Trust Plc's HY22 result.

What were the principal country, sector and stock-level detractors behind the -7.5% portfolio total return for the half?Why does "Portfolio capital reversal dominates the result" matter?How strong was the cash and earnings quality in HY22?What should I watch next for TEM after HY22?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Half-year Report

HY22 / financial report↗

Prior comparable period

Half-year Report

HY21 / financial report↗

Full-year context

Statement of Annual Results to 31 March 2021

FY21 / financial report↗

Release context

Result of AGM

HY22 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

Revenue growth context

Revenue growth was -6.3% for this reporting period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when TEM publishes next

Get the next Templeton Emerging Markets Investment Trust Plc briefing and related NZX reporting-season updates by email.